English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
Add to Basket
  Local TagsRelease HistoryDetailsSummary

Released
Journal Article

Ceftriaxone-resistant Salmonella enterica serotype Newport, France

MPS-Authors
/persons/resource/persons82133

Sangal,  Vartul
Max-Planck Research Group RNA Biology, Max Planck Institute for Infection Biology, Max Planck Society;

/persons/resource/persons81778

Achtman,  Mark
Department of Molecular Biology, Max Planck Institute for Infection Biology, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)

Emerg_inf_dis_2008_14_954.pdf
(Publisher version), 324KB

Supplementary Material (public)
There is no public supplementary material available
Citation

Egorova, S., Timinouni, M., Demartin, M., Granier, S. A., Whichard, J. M., Sangal, V., et al. (2008). Ceftriaxone-resistant Salmonella enterica serotype Newport, France. Emerging Infectious Diseases, 14(6), 954-957.


Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-C1BA-B
Abstract
The multidrug-resistant (MDR) Salmonella enterica serotype Newport strain that produces CMY-2 β-lactamase(Newport MDR-AmpC) was the source of sporadic cases and outbreaks in humans in France during 2000–2005. Because this strain was not detected in food animals, it was most likely introduced into France through imported food products.